Cargando…
Development of experimental chronic kidney disease and vascular calcification alters diurnal variation of phosphate and its hormonal regulators
The mineral‐bone axis is tightly regulated and dependent on renal function. In chronic kidney disease (CKD) progressive loss of renal capacity disrupts this axis over‐time, with marked changes in circulating calcium, phosphate, PTH, and fibroblast growth factor‐23 (FGF‐23). These changes contribute...
Autores principales: | Svajger, Bruno A., Riddoch, Justin L. H., Pruss, Cynthia M., Laverty, Kimberly J., Ward, Emilie, Holden, Rachel M., Adams, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666773/ https://www.ncbi.nlm.nih.gov/pubmed/33190417 http://dx.doi.org/10.14814/phy2.14626 |
Ejemplares similares
-
PTH suppression by calcitriol does not predict off‐target actions in experimental CKD
por: Svajger, Bruno A., et al.
Publicado: (2020) -
The Key Role of Phosphate on Vascular Calcification
por: Cozzolino, Mario, et al.
Publicado: (2019) -
Vascular Calcification: Key Roles of Phosphate and Pyrophosphate
por: Villa-Bellosta, Ricardo
Publicado: (2021) -
From organic and inorganic phosphates to valvular and vascular calcifications
por: Bäck, Magnus, et al.
Publicado: (2021) -
Neuromedin B modulates phosphate-induced vascular calcification
por: Park, Hyun-Joo, et al.
Publicado: (2021)